The Optimal Dopamine D2 Receptor Occupancy by Antipsychotics in Patients with Late-Life Schizophrenia: A [11C]-Raclopride PET Study

被引：0
|
作者：
Nakajima, Shinichiro [1 ,2 ]
Mamo, David [1 ]
Uchida, Hiroyuki [1 ,2 ]
Suzuki, Takefumi [2 ]
Rajji, Tarek [1 ]
Caravaggio, Fernando [3 ]
Gerretsen, Philip [1 ]
Mimura, Masaru [2 ]
Mulsant, Benoit [1 ]
Pollock, Bruce [1 ]
Graff-Guerrero, Ariel [1 ]
机构：
[1] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada
[2] Keio Univ, Dept Neuropsychiat, Tokyo, Japan
[3] Ctr Addict & Mental Hlth, Multimodal Imaging Grp, Toronto, ON, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
Antipsyhoctic; Schizophrenia; Late-life; Positron emission tomography; dopamine D2 receptor;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
330
引用
收藏
页码：105S / 105S
页数：1
相关论文
共 50 条
  • [1] THE OPTIMAL DOPAMINE D2/3 RECEPTOR OCCUPANCY BY ANTIPSYCHOTICS IN PATIENTS WITH LATE-LIFE SCHIZOPHRENIA: A [11C]-RACLOPRIDE PET STUDY
    Nakajima, Shinichiro
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S235 - S235
  • [2] Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457
    Ikoma, Yoko
    Ito, Hiroshi
    Arakawa, Ryosuke
    Okumura, Masaki
    Seki, Chie
    Shidahara, Miho
    Takahashi, Hidehiko
    Kimura, Yuichi
    Kanno, Iwao
    Suhara, Tetsuya
    NEUROIMAGE, 2008, 42 (04) : 1285 - 1294
  • [3] DOPAMINE D2 AND D3 RECEPTOR AVAILABILITY IN ANTIPSYCHOTIC-FREE PATIENTS WITH LATE-LIFE SCHIZOPHRENIA: A CROSS-SECTIONAL [11C]-(+)-PHNO AND [11C]-RACLOPRIDE PET STUDY
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Mamo, David
    Mulsant, Benoit
    Chung, Jun Ku
    Plitman, Eric Alexander
    Iwata, Yusuke
    Gerretsen, Philip
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mar, Wanna
    Graff-Guerrero, Ariel
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S266 - S267
  • [4] Antipsychotic Dose Reduction and Dopamine D2 receptor Occupancy in Late-Life Schizophrenia: A PET Study
    Uchida, Hiroyuki
    Kapur, Shitij
    Mulsant, Benoit H.
    Graff-Guerrero, Ariel
    Pollock, Bruce G.
    Mamo, David C.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 209S - 209S
  • [5] The relationship between subjective well-being and dopamine D2 receptor occupancy in patients with schizophrenia on aripiprazole: [11C] Raclopride PET study
    Ock, Elena
    Kim, Seoyoung
    Kim, Euitae
    ASIA-PACIFIC PSYCHIATRY, 2021, 13
  • [6] Regional distribution of dopamine D2 receptor occupancy by aripiprazole: a PET study using [11C]raclopride and [11C]FLB457
    Takahata, Keisuke
    Ito, Hiroshi
    Takano, Harumasa
    Fumitoshi, Kodaka
    Arakawa, Ryosuke
    Suhara, Tetsuya
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S43 - S44
  • [7] Dopamine D2/3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain-A Comparative PET Study With [11C]Raclopride and [11C]MNPA
    Finnema, Sjoerd J.
    Halldin, Christer
    Bang-Andersen, Benny
    Gulyas, Balazs
    Bundgaard, Christoffer
    Wikstrom, Hakan V.
    Farde, Lars
    SYNAPSE, 2009, 63 (05) : 378 - 389
  • [8] Dopamine D2 receptor occupancy studies with PET and 11C-raclopride revisited
    Willemsen, A. T. M.
    Segbers, M.
    Dierckx, R. A. J. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S308 - S308
  • [9] (11C)-N-methylspiperone PET detects different levels of dopamine D2 receptor occupancy of an atypical neuroleptic than (11C)-raclopride PET
    Hagberg, G
    Gefvert, O
    Bergström, M
    Wieselgren, IM
    Lindström, L
    Wiesel, FA
    Långström, B
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 165 - 166
  • [10] Dopamine D2 and D3 Receptor Availability in Antipsychotic-free patients with Schizophrenia in Later Life: A Cross-sectional [11C]-(+)-PHNO and [11C]-raclopride PET Study
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Mamo, David C.
    Mulsant, Benoit H.
    Chung, Jun Ku
    Plitman, Eric
    Iwata, Yusuke
    Gerretsen, Philip
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mar, Wanna
    Wilson, Alan A.
    Houle, Sylvain
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 118S - 118S
12345